Literature DB >> 1279756

Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini.

R Malhotra1, L Singh, J Eng, J P Raufman.   

Abstract

We examined the actions of exendin-4, a new peptide isolated from Heloderma suspectum venom, on dispersed acini from rat pancreas. Exendin-4 caused a 3-fold increase in cAMP but did not alter cellular calcium concentration. Exendin-4-induced increases in cAMP were inhibited by an exendin-receptor antagonist, exendin (9-39)NH2, but not by VIP-receptor antagonists. Whereas up to 1 microM exendin-4 alone did not alter amylase release, potentiation of enzyme release was observed when the peptide (greater than 30 pM) was combined with cholecystokinin. Potentiation of amylase release was also observed when exendin-4 was combined with carbamylcholine, bombesin or a calcium ionophore, A23187. These results indicate that stimulation of exendin receptors on rat pancreatic acini causes an increase in cellular cAMP. Although this increase in cAMP alone does not result in amylase release, combination of exendin-4 with agents that increase cell calcium results in potentiation of amylase release.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279756     DOI: 10.1016/0167-0115(92)90044-u

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  16 in total

1.  Drug discovery from natural sources.

Authors:  Young-Won Chin; Marcy J Balunas; Hee Byung Chai; A Douglas Kinghorn
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

2.  Pancreatic safety of GLP-1-based therapeutic agents: further insights from rodent studies?

Authors:  Jens Juul Holst
Journal:  Diabetologia       Date:  2013-07-03       Impact factor: 10.122

Review 3.  Insulin resistance in Alzheimer's disease.

Authors:  Thomas Diehl; Roger Mullins; Dimitrios Kapogiannis
Journal:  Transl Res       Date:  2016-12-13       Impact factor: 7.012

Review 4.  Mechanisms of action of glucagon-like peptide 1 in the pancreas.

Authors:  Máire E Doyle; Josephine M Egan
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

5.  Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists.

Authors:  Lei Sun; Zhi-Ming Zheng; Chang-Sheng Shao; Zhi-Yong Zhang; Ming-Wei Li; Li Wang; Han Wang; Gen-Hai Zhao; Peng Wang
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-13

6.  Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas.

Authors:  J S Nachnani; D G Bulchandani; A Nookala; B Herndon; A Molteni; P Pandya; R Taylor; T Quinn; L Weide; L M Alba
Journal:  Diabetologia       Date:  2009-09-13       Impact factor: 10.122

7.  Glucagon-like peptide-1 is a physiological incretin in rat.

Authors:  Z Wang; R M Wang; A A Owji; D M Smith; M A Ghatei; S R Bloom
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species.

Authors:  Niels C B Nyborg; Anne-Marie Mølck; Lars W Madsen; Lotte Bjerre Knudsen
Journal:  Diabetes       Date:  2012-02-14       Impact factor: 9.461

9.  Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice.

Authors:  Jacqueline A Koehler; Laurie L Baggio; Benjamin J Lamont; Safina Ali; Daniel J Drucker
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

10.  Mouse pancreas tissue slice culture facilitates long-term studies of exocrine and endocrine cell physiology in situ.

Authors:  Anja Marciniak; Claudia Selck; Betty Friedrich; Stephan Speier
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.